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Purpose: To investigate the effects of daily oral L-leucine ingestion on strength, 
bone mineral-free lean tissue mass (LTM) and fat mass (FM) of free living 
humans during a 12-wk resistance-training program. Methods: Twenty-six 
initially untrained men (n = 13 per group) ingested either 4 g/d of L-leucine 
(leucine group: age 28.5 ± 8.2 y, body mass index 24.9 ± 4.2 kg/m2) or a 
corresponding amount of lactose (placebo group: age 28.2 ± 7.3 y, body mass 
index 24.9 ± 4.2 kg/m2). All participants trained under supervision twice per week 
following a prescribed resistance training program using eight standard exercise 
machines. Testing took place at baseline and at the end of the supplementation 
period. Strength on each exercise was assessed by five repetition maximum (5-
RM), and body composition was assessed by dual energy X-ray absorptiometry 
(DXA). Results: The leucine group demonstrated significantly higher gains in 
total 5-RM strength (sum of 5-RM in eight exercises) and 5-RM strength in five 
out of the eight exercises (P < .05). The percentage total 5-RM strength gains 
were 40.8% (± 7.8) and 31.0% (± 4.6) for the leucine and placebo groups 
respectively. Significant differences did not exist between groups in either total 
percentage LTM gains or total percentage FM losses (LTM: 2.9% ± 2.5 vs 2.0% ± 
2.1, FM: 1.6% ± 15.6 vs 1.1% ± 7.6). Conclusion: These results suggest that 4 g/d 
of L-leucine supplementation may be used as a nutritional supplement to enhance 
strength performance during a 12-week resistance training program of initially 
untrained male participants. 
Keywords: ergogenic aids, resistance training, muscle growth, oral ingestion 
Leucine is one of the essential amino acids that belongs to the group of 
branched-chain amino acids (BCAA) and may play a specific and pertinent role in 
the regulation of protein turnover. It has been demonstrated clearly that leucine may 
act as nutrient signal to stimulate protein synthesis in animal studies,1,2 thus having 
the potential to enhance anabolism and act as an ergogenic aid. In humans, 
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intravenous infusion of leucine may decrease protein degradation at rest,3 while oral 
ingestion of leucine and essential amino acids may increase muscle protein synthesis 
at rest in both young and elderly individuals.4 Addition of leucine to a 
carbohydrate/protein supplement postexercise has been shown to elicit greater 
responses in the rate of muscle protein synthesis in healthy male subjects than a 
carbohydrate and a carbohydrate/protein supplement following a resistance exercise 
bout.5 However, others have suggested that coingestion of leucine and whey protein 
before exercise does not result in a greater anabolic response than whey protein 
alone.6 In terms of sports performance, leucine supplementation has been shown to 
increase time to exhaustion and the upper body power of rowers during 6 wk of 
supplementation7 to a greater extent than a placebo condition, while coingestion of 
protein and leucine during 8 wk of resistance training has shown to elicit further 
gains in one repetition maximum strength (1-RM) than a placebo (carbohydrate) and 
a control condition.8 
Bearing in mind the results of the aforementioned studies, it is probable that 
supplementation of leucine during resistance exercise training may be beneficial in 
terms of strength gains and muscle growth. Surprisingly, the capacity of orally 
ingested leucine alone to enhance strength and muscle mass in humans, while 
following an identical prescribed resistance-training program has not been tested. It 
has also been suggested that the recommended dietary intake of leucine of 14 mg·kg–
1·BW·d–1 (where BW = body weight) is inadequate in individuals who are physically 
active.9,10 At a protein intake of 1.26 g·kg–1·BW·d–1, the serum concentrations of 
amino acids are lowered considerably during training of athletes.9 Leucine 
supplementation of 50 mg·kg–1·BW·d–1 appears to prevent the decrease in the serum 
leucine concentration during training.9 Therefore, a dose of similar magnitude was 
utilized in the present study. 
The potential of leucine to stimulate primarily protein synthesis provides the 
basis and justification to ingest leucine during resistance exercise training in order to 
enhance muscle growth and ultimately improve strength and personal performance. 
An increase in muscle size is generally accompanied by an increase in strength.11 
Strength gains may lead to improved performance in athletic disciplines and 
everyday life.12 Gains in lean mass and losses in fat mass may result in physiological 
adaptations that decrease the risk of diseases such as cardiovascular disease.13 
Therefore, the main aim of the present study is to investigate the capacity of 4 g⋅d–1 
oral ingestion of leucine alone to enhance strength, lean mass and decrease fat mass 
during a 12-wk resistance-training program of initially untrained male participants. 
Our expectation was that supplementation with leucine would lead to further gains in 
muscle growth and consequently strength when compared with a placebo condition. 
Methods 
Participants 
Forty healthy males were recruited in stages. Participants who failed to follow the 
resistance training program and did not comply with our participation requirements 
described below were removed from the study. Thus, the required number of 13 
participants per group (determined by power calculation using Machin’s 
software[AUQ2] version 2) was met. The volunteers were assigned to a placebo 
group (P) (28.2 ± 7.3 y; 1.77 ± 0.10 m; 78.4 ± 16.8 kg; BMI 24.9 ± 4.2 kg⋅m–2) and a 
leucine supplemented group (L) (28.5 ± 8.2 y; 1.76 ± 0.05 m; 77.6 ± 7.9 kg; BMI 
Page 3 of 15 
24.6 ± 3.2 kg⋅m–2). Attempts were made to match pairs of participants as closely as 
possible on age and BMI. Medical history and lifestyle evaluation questionnaires 
were collected before the assignment of the participants to one of the two conditions. 
The participants had never taken part in any structured resistance training program or 
any other type of exercise training program in the past. Volunteers who had 
participated in any type of training the 6 mo preceding the baseline measurements 
were also excluded. None of the participants had diabetes, high blood pressure, or 
symptomatic disease, including cardiovascular disease. All participants were free 
from medication and were not taking any other nutritional supplements during or 
before the intervention. The study was approved by the Leeds West Research Ethics 
Committee. All participants received information sheets and had the opportunity to 
ask questions about the potential benefits, risks and design of the study before 
informed consent was obtained. 
Experimental Design and Strength Training Protocol 
The design of the study was placebo-controlled and double blind. The participants 
agreed to take part exclusively in the assigned resistance training program. Both 
groups received identical prescribed resistance training over a period of 12 wk. The 
participants were advised to maintain the same lifestyle and physical activity levels 
before the commencement of the experimental period. The standard machines used 
during the strength assessment and strength training sessions were as follows: leg 
press, bench press, chest cross, pullover, overhead press, preacher curls, triceps press 
(All Nautilus, USA) and prone leg curl (Nautilus Nitro, USA). All sessions took 
place in a university gym. The participants trained twice per week (with 2–3 rest 
days between sessions). According to the position stand of the American College of 
Sports Medicine (ACSM) the initial resistance for novice subjects should be in the 
range of 8-12 repetition maximum (RM) strength, and the training frequency 2–3 
d/wk.14 The duration of the training program was set at 12 weeks as muscle growth 
is more likely to become evident after 6–7 wk of resistance training.15 
Five repetition maximum (5-RM) testing took place at baseline, at weeks 4, 8 
and 12 of the experimental period. The participants warmed-up using a cycle 
ergometer (Startrac Pro, USA) for a period of 5 min followed by 5 min of dynamic 
arm and leg movements combined with gentle stretching of arms and legs. A 5-min 
rest was given between each trial to allow for adequate recovery. 5-RM was 
employed for assessment of strength in order to minimize the risk of injury because 
all subjects were untrained at baseline, and to determine rather than estimate the 
training loads during the strength workouts.16 Multiple RM testing between 3-RM to 
6-RM has also been shown to be a valid index of assessment of strength.16 In 
addition to measuring 5-RM strength in all eight exercises, total 5-RM was 
determined by the sum of 5-RM strength on each individual exercise. One week 
before the first 5-RM testing all participants were familiarized with the training 
equipment using light resistance. 
The training protocol combined two different types of workouts shown to 
increase strength and muscle size.17 The hypertrophy workout involved 3 sets of 10 
repetitions with 1 min of rest between sets; the training loads were adjusted in order 
to allow the participants to perform just 10 repetitions during the last set. During the 
strength workouts the resistance used was the 5-RM achieved during the previous 
assessment; participants in this case performed 4 × 5-RM with 3 min of recovery 
between sets. If for any reason participants were unable to complete 5 repetitions 
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during their final set, resistance was adjusted in a subsequent session to allow them 
to perform 5 repetitions during the final set. 
Assessment of Body Composition 
Total and regional (arms, legs and trunk) body composition was assessed at baseline 
and at the end of the supplementation period by dual energy X-ray absorptiometry 
(DXA). A DXA scanner (Prodigy Lunar, GE Medical Systems, serial No: 10395, 
USA) was used for the assessment of bone mineral-free lean tissue mass (LTM) and 
fat mass (FM). The testing took place in the Centre for Bone and Body Composition 
Research, Leeds University. DXA has been validated against other methods and has 
shown little bias based on age, fat distribution, activity levels, gender or race, while 
at the same time is a more sensitive method for assessing small and regional changes 
in body composition.18,19 
Diet and Supplements 
The participants were asked to maintain their habitual diet throughout the 
experimental period and were asked to keep diet diaries for a period of 4 d at the 
midpoint of the study to include two training, one weekend and one week 
nontraining days. The parameters assessed for dietary analysis were: carbohydrate, 
protein, fat and alcohol intake. The CompEat program 5.7 (CompEat version 5, 
Nutrition systems, Grantham, UK) was used for the analysis of diary records. The 
resting energy expenditure (REE) was calculated using the Harris-Benedict 
equation20 and the total energy requirements were estimated by multiplying REE 
with a factor of 1.35.21 
Supplementation was continuous for the duration of the study. On nontraining 
days participants were asked to take the supplements in three equal doses during the 
day (morning, midday, evening). On training days, the supplements were ingested 
immediately following exercise. The doses were 4 g⋅d–1 (approximately 50 mg·kg–
1·BW·d–1) for leucine (L-leucine white crystalline powder, Ajinomoto Co. Inc., 
Tokyo, Japan) and a corresponding amount of lactose (99% lactose monohydrate, 
Dairy Crest Ingredients, Surrey, UK). The composition of the placebo was not 
revealed to the participants. The leucine dose (4 g⋅d–1) resulted from the average 
weight for British men of 77.2 kg (Allied Dunbar National Fitness Survey);22 50 
mg·kg–1·BW·d–1 seems to be an adequate quantity to prevent a decrease in serum 
leucine concentration during intensive training of athletes.9 There was good reason 
to believe that postexercise supplementation in addition to regular supplementation 
through the day would be more likely to enhance any anabolic effect of leucine than 
daily supplementation alone. This is because previous research has shown that 
ingestion of protein and amino acid mixtures immediately after (ideally within the 
first hour) exercise can create a more anabolic environment conducive to muscle 
hypertrophy.23 Continuity of supplementation was also of significant importance as 
protein turnover may remain elevated for up to 48 h following the end of exercise.24 
We expected that ingestion of leucine at different time points during nonexercising 
days (in combination with ingestion of nutrients through their normal diet) would 
create a sustained positive or a more positive protein balance conducive to muscle 
hypertrophy throughout the day. 
The volume of each drink was approximately 150 mL and consisted of four 
parts water, one part squash (Kia-Ora, Coca Cola Enterprises Ltd) and the daily 
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supplement doses; the energy value excluding the supplements was approximately 
16 kcal (11 kcal·100 mL–1). The squash was added in the drinks in an attempt to 
disguise the taste of the supplements and in particular the bitterness of leucine. The 
energy value of 4 g⋅d–1 of lactose was 16 kcal (400 kcal·100 g–1), while the energy 
value of 4 g⋅d–1 of leucine was 24.8 kcal (6.2 kcal·g–1). Powders were dispensed in 
plastic food bags that were sealed, placed in opaque envelopes, which were labeled 
as A, or B and then distributed to the participants. The participants were instructed to 
shake well the mix in the supplied beakers (black color). As a result there were no 
residues of leucine or lactose left in the beakers. Furthermore, as the experimental 
groups were discreet groups, neither the participants in the leucine group nor the 
participants in the placebo group knew what the drink tasted like in the opposite 
group. 
Ratings of Perceived Exertion and 7-d Physical Activity Recall 
Ratings of perceived exertion (RPE) were recorded at the end of each exercise 
within each training bout to compute session RPE (average of RPE in eight 
exercises). The 6–20 Borg scale has been used in resistance training studies to 
monitor exercise intensity25 and has been found to be a very useful tool to 
distinguish between different training intensities. In addition to RPE, a 7-d physical 
activity recall (7-d PAR) interview took place at the end of the supplementation 
period. The purpose of the 7-d PAR, a reliable index in assessing activity levels26 
was to explore the activity levels of the two groups toward the end of the 
experimental period. 
Blood Samples 
Blood samples were drawn by venipuncture after a minimum of 10-h overnight fast 
at the beginning and at the end of the supplementation period to assess liver function 
(liver enzymes, bilirubin and albumin) and blood profile (standard full blood count). 
Subjects remained seated in a reclined position for 5-min before the sample was 
drawn from one of the brachial, medial cubital or radial veins. The samples were 
drawn in succession into a gold 3.5-mL (13 × 75 mm) BD SST II Vacutainer (BD 
Vacutainer Systems Preanalytical Solutions, UK) and a purple EDTA 4-mL 
Vacuette (Vacuette, Greiner Bio-One, Austria). The samples were transferred to the 
department of Clinical Biochemistry and Immunology, Leeds General Infirmary) for 
subsequent analysis. No other tests were conducted on blood sampling days. 
Statistical Analysis 
Data are presented as means (± standard deviations). Independent t test were 
employed to test for significant differences between groups in percentage strength 
and percentage LTM and FM differences (the difference between the absolute values 
expressed as percentage of the baseline value). In addition, effect sizes were 
computed by using the method of Cohen. Independent t test were also employed for 
analyzing 7-d PAR data and mean differences of blood data (postexercise absolute 
values minus baseline absolute values). Comparison of RPE data (average for each 
training session) were made using a 2-way ANOVA (condition × training sessions) 
with repeated measures across the training period for both the hypertrophy and 
strength training workouts. The alpha level of statistical significance was set at P < 
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.05. Data were analyzed using the statistical package for the social sciences, version 
16.0 (SPSS, Inc., Chicago, USA). 
Results 
Strength Variables 
Table 1 provides the descriptive statistics at baseline and end of the supplementation 
period. The percentage gains from baseline until the end of the experimental period 
in 5-RM strength for both groups ranged between 19% and 60% with a gain of 
approximately 30-40% in the majority of exercises (Table 1). On average the 
percentage 5-RM strength gains for the L group were approximately 10% higher 
than the P group. Statistical analysis on the mean percentage gains across the 12-
week experimental period showed that the L group had significantly greater 
percentage mean gains than the P group in 5 out of 8 exercises and total strength (P 
< .05) (Table 1). The statistical analysis showed significant differences between 
groups for leg press (t24 = –2.79; P = .010), bench press (t24 = –2.45; P = .02), 
pullover (t24 = –2.33; P = .03), preacher curls (t24 = –3.17; P = .004), triceps press 
(t24 = –3.47; P = .002) and total strength (t24 = –4.06; P < .001). No significant 
differences between conditions were observed for leg curls (P = .19), chest cross (P 
= .08) and overhead press (P = .35). 
 
\ Insert Table 1 \ 
 
Body Composition 
Table 2 reports the body composition variables at baseline and week 12. The mean 
gains in total bone mineral-free lean tissue mass (LTM) and losses in total fat mass 
(FM) were 1.08 kg (±1.1), 1.53 kg (±1.3) and 0.41 kg (±1.4), 0.93 kg (±3.0) on 
average for P and L groups respectively. Independent t test showed that these 
percentage changes were not significantly different between groups (LTM: t24 = –
0.94; P = .36 and FM: t24 = 0.10; P = .92). Similarly, significant differences did not 
exist between groups in LTM or FM of arm, leg and trunk regions (Table 2). 
 
\ Insert Tables 2 and 3 \ 
 
Dietary Intake 
The daily percentage contribution of different nutrients and alcohol to total energy as 
well as the total energy intakes were similar for both groups (Table 3). One 
participant from the P and two participants from the L group failed to submit their 
diet diaries. The P group met 98.2% (±24.6) and the L group 89.8% (±18.2) of the 
estimated energy requirements. The dietary grams of protein per kilogram of body 
weight were 0.88 g (±0.28) and 0.90 g (±0.15) for P and L groups respectively. 
There were no significant differences between the two groups in either absolute or 
percentage terms. 
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RPE 
Ratings of perceived exertion (RPE) during each hypertrophy workout (session RPE) 
ranged from 16.2 (±1.9) to 17.6 (±1.2) and 16.1 (±1.9) to 17.8 (±1.3) for P and L 
groups respectively. During the strength workouts session RPE ranged from 16.2 
(±1.4) to 18.3 (±0.8) and 16.3 (±1.6) to 18.1 (±1.1) for P and L groups respectively. 
Significant differences did not exist between groups. There was neither a condition 
main effect (P = .499 for hypertrophy and P = .865 for strength workouts) nor an 
interaction main effect (P = .175 for hypertrophy and P = .540 for strength 
workouts). 
7-d Physical Activity Recall 
The physical activity recall data showed no differences in the number or intensity in 
work related and/or other activity levels between both groups. 
Blood 
All blood variables were within the normal range (as provided by the Department of 
Clinical Biochemistry and Immunology, Leeds General Infirmary). No significant 
differences between groups were found. 
Discussion 
The resistance training program for the novice weight trainers employed in the 
current study was associated with positive adaptations in strength and LTM for both 
the P and L groups. The magnitude of gains for both groups was in the expected 
range of approximately 20–40% for moderately trained and untrained individuals.14 
Daily ingestion of leucine during 12 wk of resistance training was accompanied by 
significantly greater gains in 5-RM strength in five out of eight resistance exercises 
and 5-RM total strength compared with similar training with a placebo. 
The gains observed in strength in both groups in the present study are most 
likely the result of the prescribed supervised resistance training program. 
Participants were clearly instructed to refrain from any lifestyle or activity 
modifications (other than the weight training sessions) during the experimental 
period. Hence, differences between the two conditions are likely to be attributed to 
the ingestion of leucine supplementation. The groups engaged in exactly the same 
type and volume of supervised resistance exercises and received the same training 
stimulus during these sessions as indexed by similar RPE ratings for both the 
hypertrophy and strength workouts. In addition, participants did not differ in activity 
or exercise levels toward the end of the intervention program nor did they differ in 
their dietary intake. Of course, differences in genetics or muscle fiber distribution 
might result in interindividual differences in progress. Because genotype has a 
bearing on the magnitude of gains in strength and/or FFM on its own right, 
recruitment of identical twins might be the best way to test the effectiveness of 
leucine as an ergogenic aid. However, the control mechanisms in place in the present 
study provide support for the notion that leucine supplementation might act as an 
ergogenic aid in novice weight trainers. 
Our hypothesis that leucine supplementation would lead to greater gains in 
strength due to additional gains in muscle growth was supported by the strength data 
but only weakly supported by the LTM data (Table 2). The leucine group had 
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slightly higher percentage gains and losses in total LTM and FM respectively than 
the P group but none of these differences were significant. However, the small effect 
size (Table 2) in trunk and total LTM suggests that a study with a longer duration 
and a higher training frequency may have resulted in significant differences between 
groups in LTM. The current study design was implemented to improve adherence to 
the study protocol. Despite the fact that participants were only required to engage in 
training twice per week only 26 out of 40 participants completed the required 
number of training sessions. This resulted in a dropout of 35%. An aim of future 
studies would be to improve adherence to training programs. 
The dietary intakes of the participants were under the estimated energy 
requirements but all within the 15% expected underestimation27 when food diaries 
are used. Ingestion of extra amino acids through the diet, which may have favored 
one of the groups in terms of muscle protein synthesis, was not the case since the 
protein intake per kilogram of body weight was identical in both groups. Thus, the 
most likely explanation of the marginally higher gains in LTM of the L group, 
supported by a small effect size in LTM and accompanied by significantly greater 
gains in 5-RM strength, was leucine supplementation. We acknowledge that four 
days of diet records may not be adequate to estimate actual intakes across the twelve 
weeks. However, it has been shown that as dietary record duration increases, the 
accuracy and recording declines.28 
We can only speculate about the mechanisms of action since the data collected 
is not appropriate for this purpose. Coingestion of leucine and protein has shown to 
elicit a greater anabolic response in untrained individuals than carbohydrate alone or 
carbohydrate/protein,5 while removal of leucine in the presence of all other amino 
acids can decrease protein synthesis by 40%.29 Thus, it is probable that leucine 
supplementation further enhanced the rates of muscle protein synthesis in our L 
group when compared with diet alone and to some extent this is supported by the 
small effect size in LTM. Others have suggested that addition of leucine to a whey 
protein supplement before exercise does not result in greater anabolic responses than 
whey protein alone.6 However, this needs to be further investigated since neither a 
whey alone nor a leucine alone group were included in their study. The role of amino 
acids, obtained from either endogenous or exogenous sources, in enhancing the rate 
of protein synthesis cannot be ignored; as in some conditions leucine enhances 
protein synthesis only in the presence of these other amino acids.30 However, it is 
unlikely our participants were depleted of any amino acids since protein intake was 
adequate and similar in both groups and supplements were coingested with food 
during the nonexercising days. It is also unlikely the significant gains in 5-RM 
strength of L group was the result of amelioration of central fatigue since leucine 
ingestion elevates plasma leucine and BCAA concentrations without affecting 
plasma free-tryptophan and the ratio of free-tryptophan to BCAA ratio.7 
Although the dose used in the current study (4 g⋅d–1) seems to be an adequate 
amount to effect positive adaptations during 12 wk of combined resistance training 
and supplementation in novice weight trainers, different dosages of leucine (higher 
or lower) should also be tested in future studies. Older individuals seem to require 
higher doses of leucine for stimulation of protein synthesis.4 However, more 
evidence-based research to test the efficacy and safety of different dosages is 
needed, before prescription of higher dosages. In our study, there was no evidence to 
suggest that 4 g⋅d–1 leucine ingestion for a period of up to 12 wk during resistance 
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training negatively affected the health of the male participants as indicated by tests 
of liver function and full blood counts. 
Practical Applications 
The additional strength gains in the L group support the use of leucine as a diet 
supplement to improve strength and ultimately performance in everyday life and 
athletic disciplines. In cases where supplementation is deemed necessary (eg, high 
intensity, high volume exercise), supplementation could be considered and 
complement an appropriate diet. An investigation of special significance would be to 
test the hypothesis that leucine supplementation may be of benefit in diseases in 
which lean body mass is compromised by atrophy such as type II diabetes based on 
supporting evidence that leucine can attenuate body wasting.2 
Conclusion 
In conclusion, the resistance training program employed in the current study 
increased strength of initially untrained male participants regardless of whether they 
ingested leucine or a placebo. However, those participants ingesting leucine had the 
greatest increase in strength. The data therefore suggest that regular ingestion of 
leucine while undertaking a resistance training program may accentuate strength 
gains. However, given the small effect size in LTM, more research is needed before 
any concrete conclusions can be made regarding the efficacy of leucine as an 
ergogenic aid. 
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Table 1 Mean strength expressed as five repetition maximum strength (5-RM) at baseline and at the end of 
the supplementation period in eight resistance exercises and total strength 
Exercise Placebo (n = 13) Leucine (n = 13) Effect 
Size Baseline Week 12 % Mean Gain Baseline Week 12 % Mean Gain 
Leg press (kg) 171.1 ± 28.4 216.9 ± 35.1 27.0 ± 7.8 169.7 ± 26.3 232.3 ± 33.3 37.4 ± 11.0** 0.5 
Bench press (kg) 71.3 ± 12.0 93.6 ± 12.9 31.9 ± 8.7 71.5 ± 19.7 99.7 ± 22.4 41.5 ± 10.9* 0.4 
Leg curls (kg) 58.1 ± 12.4 68.3 ± 12.0 18.6 ± 7.5 58.2 ± 12.7 71.0 ± 12.5 23.0 ± 9.1 0.3 
Chest cross (kg) 56.5 ± 12.8 82.6 ± 14.4 48.2 ± 10.7 56.0 ± 17.4 87.2 ± 20.4 59.8 ± 19.9 0.3 
Pullover (kg) 71.1 ± 14.3 89.1 ± 15.4 26.3 ± 7.7 68.6 ± 15.7 92.3 ± 19.3 35.4 ± 11.9* 0.4 
Overhead press (kg) 36.1 ± 6.9 53.0 ± 8.8 48.0 ± 14.7 39.3 ± 12.9 58.9 ± 14.8 53.8 ± 16.0 0.2 
Preacher curls (kg) 47.3 ±9.0 60.4 ± 9.1 29.0 ± 9.0 46.6 ± 8.8 64.4 ± 9.9 39 ± 6.9** 0.5 
Triceps press (kg) 75.3 ± 11.1 102.6 ± 12.4 36.9 ± 7.2 76.0 ± 17.1 113.6 ± 18.1 51.7 ± 13.6** 0.6 
Total strength (kg) 587.1 ± 89.6 766.6 ± 103.7 31.0 ± 4.6 586.0 ± 115.3 819.5 ± 129.3 40.8 ± 7.4** 0.6 
* Denotes significant difference in percentage gain between the placebo and leucine condition (* P < .05; **P < .01). 
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Table 2 Bone mineral-free lean tissue mass (LTM), fat mass (FM) and soft tissue mass (STM = LTM + FM) 
by DXA at baseline and at the end of the experimental period 
Body Composition Variable Placebo (n = 13) Leucine (n = 13) 
Effect 
Size 
Baseline Week 12 % Change Baseline Week 12 % Change 
Arm FM (kg) 1.6 ±1.0 1.5± 1.0 –3.1 ± 12.7 1.8 ± 0.8 1.7 ± 0.6 –3.8 ± 12.2 0.02 
Leg FM (kg) 6.8 ± 3.0 6.5 ± 2.8 –4.4 ± 7.1 7.1 ± 1.7 6.9 ± 1.3 –1.1 ± 13.8 0.1 
Trunk FM (kg) 11.3 ± 6.2 11.2 ± 5.7 –1.3 ± 8.6 12.1 ± 4.9 11.5 ± 4.0 –1.5 ± 18.5 0.006 
Arm LTM (kg) 6.6 ± 0.9 7.0 ± 0.9 6.1 ± 5.6 6.5 ± 0.9 7.0 ± 1.1 6.5 ± 3.4 0.04 
Leg LTM (kg) 20.0 ± 2.7 20.4 ± 2.8 1.8 ± 2.5 19.6 ± 2.6 20.0 ± 2.4 1.9 ± 2.7 0.02 
Trunk LTM (kg) 27.6 ± 5.0 27.9 ± 4.9 1.3 ± 3.1 25.9 ± 2.6 26.7 ± 2.9 2.9 ± 4.3 0.2 
Total FM (Arm+Leg+Trunk) (kg) 19.7 ± 9.9 19.3 ± 9.4 –1.1 ± 7.7 21.0 ± 7.3 20.1 ± 5.6 –1.6 ± 15.6 0.02 
Total LTM (Arm+Leg+Trunk) (kg) 54.2 ± 7.9 55.2 ± 8.0 2.0 ± 2.1 52.0 ± 5.6 53.6 ± 5.9 2.9 ± 2.5 0.2 
Total STM 76.7 ± 16.7 77.4 ± 16.1 1.1 ± 2.2 75.8 ± 7.7 76.4 ± 6.6 1.0 ± 4.0 0.02 
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Table 3 Average daily dietary intakes over a period of 4 (two 
training days, one weekend day, and one nontraining weekday) 
in the middle of the training period 
Dietary Variable Placebo (n = 12) Leucine (n = 11) 
Carbohydrate intake (kcal) 1180.7 ± 344.9 1012.2 ± 210.6 
Protein intake (kcal) 393.7 ± 108.6 355.0 ± 67.2 
Fat intake (kcal) 853.5 ± 215.3 718.2 ± 165.7 
Alcohol intake (kcal) 96.6 ± 163.8 182.7 ± 290.2 
Carbohydrate (% of TEI) 48.2 ± 7.4 46.3 ± 7.5 
Protein (% of TEI) 16.0 ± 2.5 16.5 ± 3.5 
Fat (% of TEI) 34.8 ± 4.9 33.2 ± 8.0 
Alcohol (% of TEI) 4.0 ± 6.6 6.9 ± 10.1 
TEI (kcal) 2450.6 ± 554.0 2204.8 ± 444.8 
Note. TEI = total energy intake. 
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